Reconsidering the clinical assessment of resistance to slowly eliminated antimalarial drugs in high-transmission settings

Sir Nicholas White; James A Watson

doi:10.1016/s1473-3099(25)00435-9

Related publications

Article2007

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs

Ric N. Price, Grant Dorsey, Elizabeth A. Ashley, Karen I. Barnes, J. Kevin Baird, Umberto D’Alessandro, Philippe J. Guérin, Miriam K. Laufer, Inbarani Naidoo, François Nosten, Piero Olliaro, Christopher V. Plowe, Pascal Ringwald, Carol Hopkins Sibley, Kasia Stepniewska, Sir Nicholas White

Malaria Journal

Article2005

Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum

Karen I. Barnes, Sir Nicholas White

Acta Tropica

Article1985

Clinical Pharmacokinetics of Antimalarial Drugs

Sir Nicholas White

Clinical Pharmacokinetics

Article1997

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo

Sir Nicholas White

Antimicrobial Agents and Chemotherapy

Article2020

Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study

Mallika Imwong, Mehul Dhorda, Kyaw Myo Tun, Aung Myint Thu, Aung Pyae Phyo, Stéphane Proux, Kanokon Suwannasin, Chanon Kunasol, Suttipat Srisutham, Jureeporn Duanguppama, Ranitha Vongpromek, Cholrawee Promnarate, Aungkana Saejeng, Nardlada Khantikul, Rungniran Sugaram, Supinya Thanapongpichat, Nongyao Sawangjaroen, Kreepol Sutawong, Kay Thwe Han, Ye Htut, Khin Linn, Aye Aye Win, Tin Maung Hlaing, Rob W. van der Pluijm,